EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report

Christina Carfagnini iD, Manasa Kandula

Clinical Case Reports · 2026-06 · 14 (6)

DOI: 10.1002/ccr3.72750 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 27.05.2026. Verfasst von Christina Carfagnini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine University of Illinois Peoria Peoria Illinois USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant bleeding disorder. The incidence of venous thromboembolisms among HHT patients is significantly greater than the general population. However, providing therapeutic anticoagulation in patients with an increased propensity for bleeding creates a clinical dilemma. This is a case of a 58‐year‐old Caucasian female with a past medical history of HHT who was diagnosed with acute on chronic bilateral pulmonary embolisms. She was started on therapeutic anticoagulation after thoroughly considering the individual bleeding risks. She later developed upper gastrointestinal bleeding secondary to angioectasias in the stomach and duodenum that were treated with argon plasma coagulation. The patient completed a total of 6 months of therapeutic anticoagulation and another year of lower dose anticoagulation for secondary prevention. This case exemplifies that patients with HHT may be treated with anticoagulation after thorough risk benefit discussions and close monitoring for acute blood loss, as recommended by current guidelines. However, these guidelines are informed by low quality evidence and there is a lack of detailed data reported in current literature. Future studies directly comparing the safety of different anticoagulants among HHT patients are needed to inform clinical practice.

Schlagwörter

Stichwörter der Autor:innen

anticoagulantsarteriovenous malformationshereditary hemorrhagictelangiectasiavenous thromboembolism

Autor:innen und Institutionen

  • Department of Internal Medicine University of Illinois Peoria Peoria Illinois USA.

ORCID-Profile: Christina Carfagnini

Zitieren

APA

Carfagnini, C., & Kandula, M. (2026). Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report. Clinical Case Reports, 14(6). https://doi.org/10.1002/ccr3.72750

Vancouver

Carfagnini C, Kandula M. Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report. Clinical Case Reports. 2026;14(6). doi:10.1002/ccr3.72750

BibTeX
@article{Carfagnini2026,
  author = {Carfagnini, Christina and Kandula, Manasa},
  title = {Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/ccr3.72750}
}
Kostenlos starten →